# The Impact of C-reactive Protein Testing

> **NCT02758821** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 2410 (actual)

## Conditions studied

- Fever

## Interventions

- **OTHER:** No CRP will be measured onsite
- **OTHER:** CRP cut-off of 20mg/L.
- **OTHER:** CRP cut-off of 40mg/L.

## Key facts

- **NCT ID:** NCT02758821
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-08
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-09-30
- **Target enrollment:** 2410 (ACTUAL)
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758821, "The Impact of C-reactive Protein Testing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02758821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*